Q2 EPS Estimates for agilon health Cut by William Blair

agilon health, inc. (NYSE:AGL) – Investment analysts at William Blair reduced their Q2 2025 earnings per share (EPS) estimates for agilon health in a note issued to investors on Tuesday, February 25th. William Blair analyst R. Daniels now forecasts that the company will earn ($0.04) per share for the quarter, down from their previous forecast of ($0.02). William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for agilon health’s current full-year earnings is ($0.59) per share. William Blair also issued estimates for agilon health’s Q3 2025 earnings at ($0.09) EPS, Q4 2025 earnings at ($0.14) EPS, FY2025 earnings at ($0.26) EPS and FY2026 earnings at ($0.17) EPS.

Several other analysts also recently commented on the company. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $1.75 to $2.25 in a research note on Friday, January 10th. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research note on Wednesday. JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Barclays decreased their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research report on Monday, November 11th. Finally, Royal Bank of Canada increased their price target on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research report on Wednesday. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $3.95.

agilon health Stock Performance

Shares of agilon health stock opened at $3.12 on Friday. The company has a market cap of $1.29 billion, a PE ratio of -3.32 and a beta of 0.66. agilon health has a 52 week low of $1.50 and a 52 week high of $7.73. The business has a 50 day moving average price of $2.96 and a 200-day moving average price of $3.03. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

Insider Buying and Selling at agilon health

In related news, Director John William Wulf purchased 45,000 shares of the business’s stock in a transaction dated Thursday, December 5th. The stock was purchased at an average cost of $2.18 per share, with a total value of $98,100.00. Following the completion of the acquisition, the director now directly owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Karen Mcloughlin purchased 25,000 shares of agilon health stock in a transaction dated Friday, December 13th. The stock was bought at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the transaction, the director now owns 73,166 shares of the company’s stock, valued at $160,965.20. This represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 77,500 shares of company stock valued at $169,600. Company insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of agilon health during the 3rd quarter valued at $28,000. Oak Thistle LLC bought a new stake in shares of agilon health during the 4th quarter valued at $25,000. Ieq Capital LLC bought a new stake in shares of agilon health during the 4th quarter valued at $26,000. Signaturefd LLC raised its stake in shares of agilon health by 143.0% during the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after purchasing an additional 8,467 shares during the period. Finally, Humankind Investments LLC bought a new stake in shares of agilon health during the 4th quarter valued at $30,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.